Reckitt Sets Pricing Terms for Tender Offer on 2044 Mead Johnson Notes
Reckitt Benckiser Group plc announced pricing terms for a tender offer on its subsidiary Mead Johnson Nutrition Company's 2044 notes. The offer is for any and all outstanding notes.
SLOUGH, United Kingdom – Reckitt Benckiser Group plc (LSE: RKT) announced today the pricing terms for a previously disclosed cash tender offer. The offer, made by its wholly-owned subsidiary Mead Johnson Nutrition Company (MJN), concerns any and all outstanding notes due in 2044.
The company detailed the specific terms of the offer, providing noteholders with an opportunity to sell their notes back to Reckitt at a set price. The exact pricing and expiration details have now been determined as part of the ongoing process.
This move is part of Reckitt's broader financial strategy to manage its corporate debt. The repurchase of Mead Johnson Nutrition Company's notes could impact the company's leverage and future financing costs.
The tender offer is subject to certain conditions, including the acceptance of the offer and the aggregate principal amount of notes validly tendered. Reckitt is expected to provide further updates on the process.